Harrow Health Inc. (HROW)

Business: Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business.

IPO Date: 28-Sep-2007

CEO & Chairman: Mr. Mark L. Baum J.D.

CFO & Corp. Sec.: Mr. Andrew R. Boll C.F.A., C.M.A., CFA, CMA

Listing: NASDAQ: HROW

Country: United States

Headquarters: Nashville, TN

Website: https://www.harrowinc.com

Market cap: $193.00 Mln

Revenue (TTM): $6.75 Mln

Earnings (TTM): $-21.13 Mln

Cash: $50.59 Mln

Total Debt: $79.13 Mln

Insider's Holding: 8.02%

Liquidity: Low

52 Week range: $5.40 - 12.99

Shares outstanding: 27,031,100

10 Years Aggregate:

• CFO: $-38.94 Mln
• EBITDA: $-46.41 Mln
• Net Profit: $-58.70 Mln